Evaluation of the Occlusive Arterial Disease and Diabetic Angiopathy Treatment Effects by Hyperbaric Oxygenation. | Canada Hyperbarics Skip to main content
Prospective Study Medical archives (Sarajevo, Bosnia and Herzegovina) 2019

Evaluation of the Occlusive Arterial Disease and Diabetic Angiopathy Treatment Effects by Hyperbaric Oxygenation.

Begić A, Dilić M — Medical archives (Sarajevo, Bosnia and Herzegovina), 2019

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers conducted a prospective study with 80 patients to compare hyperbaric oxygen therapy combined with standard treatment versus standard treatment alone for lower-extremity wounds caused by arterial occlusive disease or diabetic angiopathy.

What They Found

The efficacy of therapy was significantly higher in patients receiving hyperbaric oxygen (HBO) therapy in addition to standard treatment compared to those receiving standard treatment alone. Specifically, significant improvement was observed in 9 patients treated with HBO therapy, whereas only 1 patient in the non-HBO treated group showed significant improvement.

What This Means for Canadian Patients

Canadian patients suffering from lower-extremity wounds due to arterial occlusive disease or diabetic angiopathy may experience improved healing outcomes with hyperbaric oxygen therapy. This suggests that adding hyperbaric oxygen to standard care could be a valuable treatment option for these challenging chronic wounds.

Canadian Relevance

This study has no direct Canadian connection as it was conducted in Bosnia and Herzegovina.

Study Limitations

A limitation of this study is its relatively small sample size of 80 patients, which may affect the generalizability of the findings.

Was this summary helpful?

Study Details

Study Type Prospective Study
Category Wound Care
Source Pubmed
PubMed ID 31762558
Year Published 2019
Journal Medical archives (Sarajevo, Bosnia and Herzegovina)
MeSH Terms Aged; Anti-Bacterial Agents; Arterial Occlusive Diseases; Diabetic Angiopathies; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperbaric Oxygenation; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Vasodilator Agents

Cite This Study

Share

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.